Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jinmi Li"'
Publikováno v:
Micromachines, Vol 13, Iss 8, p 1272 (2022)
Microchips are fundamental tools for single-cell analysis. Although various microfluidic methods have been developed for single-cell trapping and analysis, most microchips cannot trap single cells deterministically for further analysis. In this paper
Externí odkaz:
https://doaj.org/article/9a09b9ed2f884234b0b845965ff18bd3
Publikováno v:
Clinical Laboratory; 2024, Vol. 70 Issue 12, p2347-2350, 4p
Publikováno v:
Clinical Laboratory; 2024, Vol. 70 Issue 7, p1388-1391, 4p
Publikováno v:
Clinical Laboratory; 2023, Vol. 69 Issue 10, p2091-2098, 8p
Publikováno v:
Clinical Laboratory. 68
Excessive systemic inflammation plays a vital role in pathophysiology of preeclampsia (PE). The aim is to clarify the predictive value of the peripheral blood parameters including white blood cell (WBC), neutrophils, lymphocyte, monocyte, platelet co
Autor:
Mei-Yun Shang, Jin Li, Li Wenman, Qing Huang, Shaoli Deng, Xian-Ge Sun, Dan Liao, Kun Wei, Weiping Lu, Jinmi Li, Bo-Wen Li, Ning Su, Qi-Qi Liu
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology
Circulating tumor cells (CTCs) play a crucial role in solid tumor metastasis, but obtaining high purity and viability CTCs is a challenging task due to their rarity. Although various works using spiral microchannels to isolate CTCs have been reported
Publikováno v:
Clinical laboratory. 66(11)
BACKGROUND To evaluate the diagnostic value of peripheral blood parameters including white blood cell (WBC), neutrophil, lymphocyte, monocyte, platelet, mean platelet volume (MPV), platelet distribution width (PDW), mean corpuscular volume (MCV), red
Publikováno v:
Clinical laboratory. 66(8)
Background Cell population data (CPD) are leukocyte morphologic parameters, measured by automated hematology analyzers with VCS technology. Many studies have demonstrated that these parameters may have clinical utility for diagnosing or screening cer
Autor:
Xiaoying Hou, Hongzhi Du, Yufei Deng, Haiping Wang, Jinmi Liu, Jialu Qiao, Wei Liu, Xiji Shu, Binlian Sun, Yuchen Liu
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Temozolomide (TMZ) is the preferred chemotherapy strategy for glioma therapy. As a second-generation alkylating agent, TMZ provides superior oral bio-availability. However, limited response rate (less than 50%) and high incidence
Externí odkaz:
https://doaj.org/article/1b5663a4788244b697639334664472d4
Publikováno v:
Clinical Laboratory; 2020, Vol. 66 Issue 8, p1501-1508, 8p